Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

June 30, 2009

Study Completion Date

February 28, 2010

Conditions
Breast Cancer
Interventions
BIOLOGICAL

trastuzumab

DRUG

CMF regimen

DRUG

cyclophosphamide

DRUG

fluorouracil

DRUG

methotrexate

Trial Locations (13)

1000

Institut Jules Bordet, Brussels

2020

Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp

2193

Medical Oncology Centre of Rosebank, Johannesburg

11000

Institute of Oncology and Radiology of Serbia, Belgrade

21079

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

DK-2730

Herlev Hospital - University Hospital of Copenhagen, Copenhagen

Unknown

National Cancer Institute of Egypt, Cairo

1091 HA

Onze Lieve Vrouwe Gasthuis, Amsterdam

2300 CA

Leiden University Medical Center, Leiden

NL-6500 HB

Nijmegen Cancer Center at Radboud University Medical Center, Nijmegen

80-211

Medical University of Gdansk, Gdansk

G11 6NT

Western Infirmary, Glasgow

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00036868 - Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter